BBC News and Press, Virtus LifeSci Biotech Clinical Trials From 03/29/25

2025-03-29 00:50:00 ET Summary The U.S. stock market is struggling to find stability amid shifting economic policies, trade tensions, and concerns about stagflation. Tariffs announced this quarter are triggering retaliatory measures from trade partners such as Canada, China, and t...

2025-03-28 06:05:00 ET Summary Since the February peak, equity markets experienced a savage reversal in leadership, momentum and investor confidence. Uncertainty around U.S. government policy – particularly tariffs – is resulting in elevated levels of market volatili...

2025-03-23 07:18:46 ET Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Spotify . Read the full article on Seeking Alpha For further details see: Wall Street Week Ahead

2025-03-20 16:32:00 ET Summary ESG policies may appear to have been put on the back burner following Trump’s re-election and the EU’s Omnibus proposal. We think they’re here to stay in the long term when it comes to healthcare. The transition is still in i...

2025-03-19 04:20:00 ET Summary Imports of goods into the US soared in January by a record amount. Pharmaceutical preparations grew by $5.2 billion, or 87% of the increase in consumer goods imports. Outside of computers and peripherals, one sees little evidence of tariff avoida...

2025-03-18 11:36:00 ET Summary The DeepSeek rollout and major public policy reversals delivered sharp but short-lived market drops in recent weeks. The downshift in sentiment across consumers, small businesses, and investors in recent weeks could increase market vulnerability to s...

2025-03-11 03:40:00 ET Summary AI is no longer just a disruptor but a defining force across industries, forcing companies to integrate or risk obsolescence. Global investment themes are shifting toward infrastructure, cybersecurity, and energy expansion as demand outpaces supply i...

2025-03-10 12:17:00 ET Summary Are these tariffs a short-term pressure tactic or a long-term shift in trade policy? Either way, they are reshaping global supply chains, creating new risks and opportunities for investors. The idea of a U.S. gold revaluation is making the rounds, th...

2025-03-02 08:33:07 ET Summary Biotech stocks are oversold. This near-term bottom might be the start of a long-term bull run. IBB and XBI offer different advantages. IBB can benefit from the flight to safety trade. XBI provides more leverage to the biotech turnaround trade. Fa...

2025-02-28 05:20:00 ET Summary Many healthcare stocks have underperformed the S&P 500. There are some pockets of strength though. Risk of overregulation remains a headwind. Many stocks in the healthcare sector have trailed the wider markets, but are there pockets...